FiBreath

A patent-protected platform transforming systemic drug delivery through the deep lung, achieving therapeutic onset in minutes.

Health Tech & Life Sciences
Stealth Mode
Pre-Funding Haifa, Israel Founded 2025
Last updated 2026-07-20
Total raised
$351K
Last: Grant 2025-07
Stage
Pre-Funding
Founded
2025
Headcount
2
HQ
Haifa, Israel
Sector
Health Tech & Life Sciences

About

FiBreath is a patent-protected platform that partners with pharmaceutical companies to deliver complex biologics and acute crisis treatments directly through the deep lung, achieving therapeutic onset in minutes. The technology utilizes engineered fiber particles designed for deep-lung penetration, bypassing the throat and upper airways. FiBreath aims to streamline clinical trials by potentially lowering required doses, leading to fewer side effects, faster metabolic clearance, and predictable clinical outcomes. The company positions itself at the intersection of delivery science and pharma commercial demand, targeting the global inhaled biologics market.

Funding history · 1 round · $351K total

2025
Grant $351K
★ BizTEC★ Reichman University★ Israel Innovation Authority★ Bronica Entrepreneurship Center at the Technion★ Technion Innovation and Entrepreneurship Hub (t:hub)

Q&A

What is FiBreath's primary focus?
FiBreath is developing a novel inhaled-therapy platform designed for deep-lung delivery to address the global burden of respiratory disease, specifically targeting asthma and COPD patients.
When was FiBreath founded?
FiBreath was founded in July 2025.
What is FiBreath's business model?
FiBreath's business model focuses on licensing its platform to leading pharmaceutical and inhaler manufacturers in exchange for royalties.
What is FiBreath's current funding stage?
FiBreath is currently in the Pre-Funding stage.
Who are the founders of FiBreath?
The founders of FiBreath are Hai Zaguri (CEO) and Ron Bessler (CTO).
What is the total amount of funding FiBreath has raised?
FiBreath has raised a total of $9,000 USD.
Which investor participated in FiBreath's Grant round?
BizTEC participated in FiBreath's Grant round in July 2025.

Team · 2

Hay Zagory
Founder · Co-Founder & CEO
Dr. Ron Bessler
Founder · CTO & Co-Founder

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug Delivery
Target customers
Healthcare & Life SciencesHealthcareProvidersInsurance CompaniesLife SciencesPharmaceuticalsBiotechnologyMedical Devices IndustryMedical Products
Business model
B2B

Highlights

Verified

Tags

inhalationasthmarespiratorystealthmodedrug-delivery
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitefibreath.com
LinkedInlinkedin.com/company/107954894

Identifiers & details

Founded2025-7
Employees (exact)2

Radar intelligence

Web history (Wayback)

Domainfibreath.com

Certificate / subdomain footprint

Subdomains2